• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Bigfoot Biomedical

Biotech, pharma chime in over Trump’s move to halt immigration program

September 6, 2017 By Sarah Faulkner

On Tuesday, biotech and pharmaceutical companies urged president Donald Trump to reconsider his decision to end former president Barack Obama’s policy protecting undocumented immigrants who arrived in the U.S. as children. Attorney general Jeff Sessions said Tuesday morning that Trump would move to halt the Deferred Action for Childhood Arrivals program in six months, unless […]

Filed Under: Biotech, Legal News, Pharmaceutical, Wall Street Beat Tagged With: Acorda Therapeutics, Alnylam Pharmaceuticals Inc., Bigfoot Biomedical, Biogen, decibeltherapeutics, Juno Therapeutics, ovidtherapeutics

Why Abbott’s CEO is excited about Bigfoot Biomedical and diabetes treatment

July 21, 2017 By Sarah Faulkner

Just one week after Abbott (NYSE:ABT) said it inked a deal with Bigfoot Biomedical to develop an automated diabetes management system, CEO Miles White told analysts that he thinks Bigfoot is playing an important role in the strategic change taking place in the space. “It’s a fairly clever service and approach that I think will create, not just an […]

Filed Under: Diabetes, Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Abbott, Bigfoot Biomedical

Bigfoot Biomedical’s CEO talks disruption in diabetes management tech

July 14, 2017 By Sarah Faulkner

Bigfoot Biomedical is a highly competitive player in medtech’s race to develop an artificial pancreas. The 50-person company has made rapid progress towards developing a smart, automated insulin delivery system since its beginnings in 2014. Just yesterday Bigfoot announced that it is partnering with Abbott, bringing together Abbott’s FreeStyle Libre glucose monitoring tech and Bigfoot’s insulin […]

Filed Under: Diabetes, Digital Health, Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceutical, Software / IT, Wall Street Beat Tagged With: Bigfoot Biomedical

Bigfoot Biomedical taps Abbott to collaborate on automated insulin delivery tech

July 13, 2017 By Sarah Faulkner

Abbott (NYSE:ABT) and Bigfoot Biomedical said today that the companies inked a deal to develop and commercialize diabetes management systems. The collaboration will bring together Abbott’s FreeStyle Libre glucose monitoring tech and Bigfoot’s insulin delivery platform, the companies reported. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Diabetes, Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Abbott, Bigfoot Biomedical

Bigfoot buys connected insulin pen tech

June 8, 2017 By Sarah Faulkner

Artificial pancreas developer Bigfoot Biomedical said today that it acquired Patients Pending and its connected insulin pen technology for an undisclosed amount. With this acquisition, Bigfoot said it is the 1st company to simultaneously pursue both insulin infusion and injection delivery solutions. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Diabetes, Drug-Device Combinations, Mergers & Acquisitions, Patient Monitoring, Pharmaceutical, Wall Street Beat Tagged With: Bigfoot Biomedical

Artificial pancreas: These companies are racing to make one

May 25, 2017 By Chris Newmarker

Medical device companies are close to achieving the holy grail of diabetes treatment: a combined glucose sensor, control algorithm and insulin infusion device that effectively acts as an “artificial pancreas.” We explain more in the newest video from editors at MassDevice’s sister publication Medical Design & Outsourcing. (And for a deeper dive, check out our recent […]

Filed Under: Diabetes, Digital Health, Drug Pumps, Drug-Device Combinations Tagged With: admetsys, Animas, Artificial pancreas, Beta Bionics, Bigfoot Biomedical, Defymed, Dexcom, diabetes, Insulet, MedTech, Medtronic, Semma Therapeutics, tandemdiabetes, TypeZero Technologies, University of Virginia

7 companies in the race to make an artificial pancreas

March 31, 2017 By Fink Densford

Over 50 years ago, scientists discovered the ability to externally control blood glucose regulation for individuals with type 1 diabetes. Since then, researchers in the field of diabetes management have dreamt of creating a closed-loop system – a combined glucose sensor, control algorithm and insulin infusion device – to effectively act as an “artificial pancreas” […]

Filed Under: Diabetes Tagged With: Bigfoot Biomedical, Medtronic

JDRF backs Bigfoot Biomedical with equity investment

January 26, 2017 By Brad Perriello

The Juvenile Diabetes Research Foundation said today that its T1D Fund made an unspecified equity investment in Bigfoot Biomedical and the Smartloop automated insulin delivery system it’s developing. “We are thrilled to have a fund associated with the world’s largest nonprofit funder of [Type I diabetes] research as an investor,” Bigfoot president & CEO Jeffrey Brewer […]

Filed Under: Diabetes, Funding Roundup, Wall Street Beat Tagged With: Bigfoot Biomedical, Juvenile Diabetes Research Foundation (JDRF)

Bigfoot Biomedical raises $36m Series A for Smartloop artificial pancreas program

October 20, 2016 By Brad Perriello

Bigfoot Biomedical said yesterday that it raised $35.5 million in a Series A round for the artificial pancreas technology it’s developing to treat Type I diabetes. The round, led by Quadrant Capital Advisors, included backing from Cormorant Asset Management, Senvest Capital, and Visionnaire Ventures. Bigfoot said it plans to use the proceeds to fund the final development of […]

Filed Under: Diabetes, Funding Roundup, Wall Street Beat Tagged With: Bigfoot Biomedical, Venture Capital/Private Equity

Bigfoot Biomedical launches artificial pancreas trial

July 25, 2016 By Mark Hollmer

Bigfoot Biomedical is launching a clinical trial of its Smartloop automated insulin delivery system at medical centers in California and Colorado. The Milpitas, Calif.-based company said it has enrolled its 1st patients in a trial of its Smartloop device that will be conducted at three sites: Stanford University School of Medicine (working with Lucile Packard Children’s […]

Filed Under: Clinical Trials, Diabetes Tagged With: Bigfoot Biomedical

Bionic pancreas dev Bigfoot Biomedical reels in $2.4m

January 26, 2016 By Fink Densford

Bionic pancreas developer Bigfoot Biomedical raised $2.4 million in a new round of debt financing, according to an SEC filing posted yesterday. The company, while staying mostly under the radar, is developing a closed-loop device combo that would continuously monitor glucose levels and deliver insulin based on a proprietary algorithm. The now Milpitas, Calif.-based medical […]

Filed Under: Business/Financial News, Diabetes Tagged With: Bigfoot Biomedical

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS